Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire

Molecular Immunology

Volumn 39, Issue 3-4, 2002, Pages 127-137

  Engelhard, Victor H ^a   Brickner, Anthony G ^a   Zarling, Angela L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Antigen processing; Class I MHC molecules; Mass spectrometry; Peptides; Post translational modification

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; MINOR HISTOCOMPATIBILITY ANTIGEN; MONOPHENOL MONOOXYGENASE; PEPTIDE; PROTEASOME;

ANTIGEN PRESENTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; CYSTEINE ENDOPEPTIDASES; ENDOPLASMIC RETICULUM; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MINOR HISTOCOMPATIBILITY ANTIGENS; MOLECULAR SEQUENCE DATA; MONOPHENOL MONOOXYGENASE; MULTIENZYME COMPLEXES; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 0036777290     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(02)00096-2     Document Type: Review

References (125)

1. Protein tyrosine kinases: Structure, substrate specificity, and drug discovery
2. Identification of a TAP-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen
3. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy
4. Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL
5. An N-glycosylated tyrosinase epitope associates with newly synthesized MHC class I molecules in melanoma cells
6. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies
7. Factors controlling the trafficking and processing of a leader-derived peptide presented by Qa-1
8. A common temperature-sensitive allelic form of human tyrosinase is retained in the endoplasmic reticulum at the non-permissive temperature
9. Ubiquitin and the control of protein fate in the secretory and endocytic pathways
10. Genes coding for T cell-defined tum transplantation antigens: Point mutations, antigenic peptides, and subgenic expression
11. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide
12. A tyrosinase non-apeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes
13. The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing
14. ER-associated and proteasome-mediated protein degradation-How two topologically restricted events came together
15. Minimal requirements for peptide mediated activation of CD8+ CTL
16. Manipulation of avidity to improve effectiveness of adoptively transferred CD8+ T cells for melanoma immunotherapy in human MHC class I-transgenic mice
17. The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice
18. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames
19. Bacterial proteins can be processed by macrophages in a transporter associated with antigen processing-independent, cysteine protease-dependent manner for presentation by MHC class I molecules
20. Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway
21. Oncogenes and signal transduction
22. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein-Barr virus in late disease
23. Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations
24. Efficient expression of tum-antigen P91A by transfected subgenic fragments
25. Ubiquitin-mediated proteolysis: Biological regulation via destruction
26. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines
27. Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines
28. Conservation of minor histocompatibility antigens between human and non-human primates
29. The minor histocompatibility antigen HA-1: A diallelic gene with a single amino acid polymorphism
30. Identification of a graft versus host disease-associated human minor histocompatibility antigen
31. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum
32. Structure of peptides associated with class I and class II MHC molecules
33. Structure of peptides associated with MHC class I molecules
34. Mass spectrometric analysis of peptides associated with the human class I MHC molecules HLA-A2.1 and HLA-B7 and identification of structural features that determine binding
35. Class I-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site-Implications for the mechanism of processing of viral envelope proteins
36. Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides
37. Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-golgi network protease furin
38. b epitope is encoded by a novel mouse Y chromosome gene
39. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells
40. Transport-independent processing of HIV-1 envelope protein for recognition by CD8+ T cells
41. Direct identification of an endogenous peptide recognized by multiple HLA-A2.1 specific cytotoxic T cells
42. HLA-A2.1 associated peptides from a mutant cell line: A second pathway of antigen presentation
43. The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene
44. Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein
45. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling
46. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry
47. Cooperation between oncogenes
48. MHC class I-restricted CTL responses to exogenous antigens
49. Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses
50. Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes
51. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1,-A2, and-A3 alleles
52. Gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+ T cells
53. Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: Implications for tumor vaccine development
54. CD4+ T cells from peripheral blood of a melanoma patient recognize peptides derived from non-mutated tyrosinase
55. Tyrosinase epitope recognized by an HLA-DR-restricted T cell line from a Vogt-Koyanagi-Harada disease patient
56. How the cyclin became a cyclin: Regulated proteolysis in the cell cycle
57. A role for a novel luminal endoplasmic reticulum aminopeptidase in final trimming of 26S proteasome-generated major histocompatability complex class I antigenic peptides
58. Substrate targeting in the ubiquitin system
59. Post-translational side chain modification of a viral epitope results in diminished recognition by specific T cells
60. Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2
61. Intramembrane proteolysis of signal peptides: An essential step in the generation of HLA-E epitopes
62. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4a
63. Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins
64. Proteasomes can either generate or destroy MHC class I epitopes: Evidence for non-proteasomal epitope generation in the cytosol
65. Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors
66. Structure of the gene of tum-transplantation antigen P91A: The mutated exon encodes a peptide recognized with Ld by cytolytic T cells
67. Alloreactive CD8+ T cells can recognize unusual, rare, and unique processed peptide per MHC complexes
68. Presentation of out-of-frame peptide-MHC class I complexes by a novel translation initiation mechanism
69. The HLA-A*0201-restricted HY antigen contains a post-translationally modified cysteine that significantly affects T cell recognition
70. Minors held by majors. The H13 minor histocompatibility locus defined as a peptide per MHC class I complex
71. An endoplasmic reticulum protein implicated in chaperoning peptides to major histocompatibility class I is an aminopeptidase
72. Selectivity of MHC-encoded peptide transporters from human, mouse and rat
73. A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes
74. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
75. Tyrosinase degradation via two pathways during reverse translocation to the cytosol
76. The class I antigen processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol
77. Melanosomes are specialized members of the lysosomal lineage of organelles
78. Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection
79. Mechanisms of MHC class I-Restricted antigen processing
80. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues
81. Cutting edge: The HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique
82. The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein
83. Distinct protein sorting and localization to premeanosomes, melanosomes, and lysosomes in pigmented melanocytic cells
84. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection
85. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis
86. Alternative processing pathways for MHC class I-restricted epitope presentation to CD8+ cytotoxic T lymphocytes
87. Antigen processing in vivo and the elicitation of primary CTL responses
88. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
89. Identification of a mouse male-specific transplantation antigen, H-Y
90. Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules
91. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules
92. Sequencing the primordial soup
93. Cancer cell cycles
94. Structure of the gene of tum-transplantation antigen P198: A point mutation generates a new antigenic peptide
95. Minor histocompatibility antigens
96. An HLA-A2 restricted tyrosinase antigen on melanoma cells results from post-translational modification and suggests a novel processing pathway for membrane proteins
97. Trimming of antigenic peptides in an early secretory compartment
98. The law of mass action governs antigen-stimulated cytolytic activity of CD8+ cytotoxic T lymphocytes
99. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response
100. Melanoma-specific CD4+ T cells recognize non-mutated HLA-DR-restricted tyrosinase epitopes
101. Antigen recognition by class I-restricted T lymphocytes
102. The molecular basis of oculocutaneous albinism type 1 (OCA1); Sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation
103. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1
104. Recognition principle of the TAP transporter disclosed by combinatorial peptide libraries
105. Translation rate of human tyrosinase determines its N-linked glycosylation level
106. A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strains
107. The peptide-binding motif for the human transporter associated with antigen processing
108. T cells discriminate between differentially phosphorylated forms of αB-crystallin, a major central nervous system myelin antigen
109. Immunodominant and subdominant CTL responses to listeria monocytogenes infection
110. Identification of classical minor histocompatibility antigen as cell-derived peptide
111. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen
112. Human H-Y: A male-specific histocompatibility antigen derived from the SMCY protein
113. TAP prefers to transport melanoma antigenic peptides which are longer than the optimal T cell epitope: Evidence for further processing in the endoplasmic reticulum
114. Capture and processing of exogenous antigens for presentation on MHC molecules
115. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides
116. Release of signal peptide fragments into the cytosol requires cleavage in the transmembrane region by a protease activity that is specifically blocked by a novel cysteine protease inhibitor
117. Transporter (TAP)-and proteasome-independent presentation of a melanoma-associated tyrosinase epitope
118. Two tyrosinase non-apeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes
119. Glycan-regulated antigen processing of a protein in the endoplasmic reticulum can uncover cryptic cytotoxic T cell epitopes
120. A post-translational modification of nuclear proteins, N(G), N(G)-dimethyl-Arg, found in a natural HLA class I peptide ligand
121. Mining genomes: Correlating tandem mass spectra of modified and unmodified peptides to sequences in nucleotide databases
122. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes
123. Phosphorylated peptides are naturally processed and presented by MHC class I molecules in vivo